NuCana plc (NCNA) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan NuCana PLC (NCNA)

Clinical phase delays are hindering sales expansion, which correlates with the volatility seen in quarterly earnings per share dynamics for NuCana plc (NCNA). Meanwhile, -248.30 shapes the current metric. Growth potential is based on the ProTide technology that destroys tumor DNA, while operational flexibility is ensured by fully outsourcing production and trials to external partners.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan NuCana (NCNA): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan NuCana plc

- nilai pasar lan prakiraan target analis:
Analisis fundamental perusahaan:NuCana PLC, NCNA
Produk asil prodhuksi NuCana plc

To assess the credit quality of NuCana plc (NCNA), the analyst examines the quarterly EPS growth vector, which measures net income per share dynamics relative to revenue and margins to exclude fictitious returns. The stability of this metric is supported by a clinical trial outsourcing model via CRO vendors, which minimizes capital expenditures and confirms the reality of financial expansion without excessive operating costs.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma, Inc.|CHRS: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CRDF|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BeyondSpring Inc. BYSI|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kazia (KZIA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan silexion.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc